REKIN - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 900,091 | 892,220 | 327,157 | 589,125 | 570,278 | 124,701 | 79,300 | 9,200 |
| Profit before tax | 23,514 | -49,697 | 30,730 | 214,002 | 147,757 | -5,801 | -45,214 | -50,753 |
| Net profit | 22,360 | -49,697 | 26,120 | 204,330 | 125,375 | -5,801 | -45,214 | -50,753 |
| Equity | -105,554 | -155,252 | -122,211 | 85,494 | 204,799 | 127,998 | -607 | -51,360 |
| Liabilities | 575,886 | 489,717 | 406,646 | 514,467 | 146,910 | 80,657 | 75,541 | 73,000 |
| Non-current assets | 55,666 | 4,330 | 2,193 | 62,554 | 71,469 | 14,120 | 10,564 | 5,054 |
| Current assets | 414,666 | 330,135 | 282,242 | 537,407 | 280,119 | 194,407 | 64,244 | 16,586 |
| Total assets | 470,332 | 334,465 | 284,435 | 599,961 | 351,588 | 208,527 | 74,808 | 21,640 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 75,945 | 16,040 | - |
| Social insurance contributions | - | - | - | - | - | 15,057 | 13,072 | 5,356 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +26.5% | -0.9% | -63.3% | +80.1% | -3.2% | -78.1% | -36.4% | -88.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.8% | -14.9% | 9.2% | 34.1% | 35.7% | -2.8% | -60.4% | -234.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | 239.0% | 61.2% | -4.5% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.5% | -5.6% | 8.0% | 34.7% | 22.0% | -4.7% | -57.0% | -551.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.6% | -5.6% | 9.4% | 36.3% | 25.9% | -4.7% | -57.0% | -551.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 6.0 | 0.7 | 0.6 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 77,706 | 112,701 | 68,875 | 107,114 | 95,046 | 21,687 | 16,407 | 2,300 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
REKIN - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-16 | 2025-10-30 | 3.90 |
| 2025-09-17 | 2025-10-12 | 3.95 |
| 2025-09-07 | 2025-09-08 | 2.40 |
| 2025-08-31 | 2025-09-03 | 2.40 |
| 2025-08-19 | 2025-08-29 | 2.40 |
| 2021-11-16 | 2021-12-12 | 0.01 |
REKIN - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-01-15 | 2025-01-15 | 1.05 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
REKIN, UAB (code 121540470) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the latest financial year, revenue decreased to €9.2K from €79.3K in 2024 and €124.7K in 2023, showing a sharp two-year contraction and an 88.4% year-on-year decline. The company remained loss-making, with net loss widening to €50.8K in 2025 from €45.2K in 2024 and €5.8K in 2023. Because sales were very low, the loss relative to revenue was exceptionally severe in 2025. Total assets fell to €21.6K from €74.8K a year earlier and €208.5K in 2023, while equity remained negative at €51.4K and liabilities stood at €73.0K. Asset turnover was 0.43x. Revenue per employee was €2.3K, indicating limited operating scale. Return measures are heavily affected by the negative equity position.